1. Home
  2. BCAB vs PMEC Comparison

BCAB vs PMEC Comparison

Compare BCAB & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • PMEC
  • Stock Information
  • Founded
  • BCAB 2007
  • PMEC 1984
  • Country
  • BCAB United States
  • PMEC Singapore
  • Employees
  • BCAB N/A
  • PMEC N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • PMEC
  • Sector
  • BCAB Health Care
  • PMEC
  • Exchange
  • BCAB Nasdaq
  • PMEC Nasdaq
  • Market Cap
  • BCAB 22.3M
  • PMEC 30.5M
  • IPO Year
  • BCAB 2020
  • PMEC 2023
  • Fundamental
  • Price
  • BCAB $0.41
  • PMEC $1.23
  • Analyst Decision
  • BCAB Buy
  • PMEC
  • Analyst Count
  • BCAB 2
  • PMEC 0
  • Target Price
  • BCAB $1.00
  • PMEC N/A
  • AVG Volume (30 Days)
  • BCAB 421.1K
  • PMEC 77.8K
  • Earning Date
  • BCAB 05-06-2025
  • PMEC 12-31-2024
  • Dividend Yield
  • BCAB N/A
  • PMEC N/A
  • EPS Growth
  • BCAB N/A
  • PMEC N/A
  • EPS
  • BCAB N/A
  • PMEC N/A
  • Revenue
  • BCAB $11,000,000.00
  • PMEC $74,310,000.00
  • Revenue This Year
  • BCAB N/A
  • PMEC N/A
  • Revenue Next Year
  • BCAB N/A
  • PMEC N/A
  • P/E Ratio
  • BCAB N/A
  • PMEC N/A
  • Revenue Growth
  • BCAB N/A
  • PMEC 3.94
  • 52 Week Low
  • BCAB $0.24
  • PMEC $0.49
  • 52 Week High
  • BCAB $2.53
  • PMEC $1.37
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 50.31
  • PMEC 57.35
  • Support Level
  • BCAB $0.37
  • PMEC $1.12
  • Resistance Level
  • BCAB $0.42
  • PMEC $1.25
  • Average True Range (ATR)
  • BCAB 0.04
  • PMEC 0.09
  • MACD
  • BCAB -0.01
  • PMEC -0.01
  • Stochastic Oscillator
  • BCAB 35.88
  • PMEC 66.53

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About PMEC Primech Holdings Ltd.

Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.

Share on Social Networks: